ClinicalTrials.gov
public full text
Public Domain
A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy
This is a non-randomized, open-label, dose-escalating Phase Ia study performed at a single center designed to evaluate the safety, pharmacokinetics, and preliminary efficacy of intravitreous administration of RNA-144101 in patients with geographic atrophy (GA).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Itraconazole to Prevent Recurrent Barrett's Esophagus#1214695
- Gene Therapy Trial for CLN6 Batten Disease#1197689
- GDNF Gene Therapy for Multiple System Atrophy#1351554
- Trial to Compare Radiation Fibrosis With Five Versus Three Fractions#1182553
- A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease#1243848
Record · ID 1292375
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive